-
Intercept Jumps 5%, Confirms FDA's Unanimous Decision To Recommend Accelerated Ocaliva Approval
Friday, April 8, 2016 - 7:29am | 240Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) were trading higher by 5 percent early Friday morning after the company announced the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee voted to recommend Ocaliva. The committee voted unanimously at 17 to 0...
-
Salix Pharmaceuticals (SLXP) Shares Up Nearly 20%
Wednesday, February 24, 2010 - 11:49am | 99Shares of Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) skyrocketted today, a day after the Gastrointestinal Drugs Advisory Committee of the FDA voted 14 to 4 in favor of the use of the company's XIFAXAN (rifaximin) 550 mg Tablets for the maintenance of remission of hepatic encephalopathy. BMO...